Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kela is a prominent Belgian pharmaceutical company that specializes in the development, manufacturing, and commercialization of products for both human and veterinary health. Founded in 1941 and headquartered in Hoogstraten, the company has established itself as a global leader in folic acid-based pharmaceuticals, notably through its flagship brand Folavit. Kela operates state-of-the-art, GMP-certified manufacturing facilities where it produces a wide range of dosage forms, including injectables, tablets, and oral liquids. In addition to its own product portfolio, the company serves as a significant contract manufacturing organization (CMO) for international pharmaceutical partners. Its veterinary division is equally robust, offering a comprehensive suite of antibiotics, vitamins, and mineral supplements to the global animal health market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kela.